Sarvmangla Samarpan Aarogya Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 09-07-2024
- Paid Up Capital ₹ 2.02 Cr
as on 09-07-2024
- Company Age 13 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -97.66%
(FY 2022)
- Profit 50.22%
(FY 2022)
- Ebitda -1084.42%
(FY 2022)
- Net Worth -4.00%
(FY 2022)
- Total Assets -22.71%
(FY 2022)
About Sarvmangla Samarpan Aarogya
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.02 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Gupta and Suman Lata serve as directors at the Company.
- CIN/LLPIN
U85100DL2011PTC218916
- Company No.
218916
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 May 2011
- Date of AGM
30 Jun 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
East Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sarvmangla Samarpan Aarogya?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Gupta  | Director | 01-Dec-2016 | Current |
| Suman Lata | Director | 21-May-2011 | Current |
Financial Performance and Corporate Structure Insights of Sarvmangla Samarpan Aarogya.
Sarvmangla Samarpan Aarogya Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 97.66% decrease. The company also saw a substantial improvement in profitability, with a 50.22% increase in profit. The company's net worth dipped by a decrease of 4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sarvmangla Samarpan Aarogya?
In 2019, Sarvmangla Samarpan Aarogya had a promoter holding of 96.52% and a public holding of 3.48%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Maasarvmangla Herbals Private Limited
Active 8 years 4 monthsSanjay Gupta and Suman Lata are mutual person
Sarvmangla Samarpan Aarogya Foundation
Active 12 years 7 monthsSanjay Gupta and Suman Lata are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sarvmangla Samarpan Aarogya?
Unlock and access historical data on people associated with Sarvmangla Samarpan Aarogya, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sarvmangla Samarpan Aarogya, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sarvmangla Samarpan Aarogya's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
